Sinphar Pharmaceutical Co. Ltd. · TWSE:1734
Sinphar Pharmaceutical — 2026 Investor Conference
27 slides from Sinphar Pharmaceutical's conference presentation, Sep 16, 2026
Slide 1: Sinphar Pharmaceutical 2026 Investor Conference
SINPHAR PHARMACEUTICAL CO., LTD. 2026 Investor Conference Vice President: Chih Hsiao Chen September 16, 2026 1
Slide 2: Disclaimer
Disclaimer 本簡報是建立於本公司從各項來源所取得之資訊。有些 訊可能受未來不確定性因素影響，致使與原先本公司對 於未來前景的說明迥異。未來若有變更或調整時，請以 公開資訊觀測站公告資訊為依據。 所涉產業為法規高度規範與高度專業領域，提醒投資人 須審慎投資。 This presentation is based on the information obtained from various sources which the Company believes to be reliable. But at some point in the future, there ar
Slide 3: Contents
Contents 1. Operations Development 2. Financial Reports 3. Sustainable Development 3
Slide 4: From Taiwan to the World
From Taiwan to the World 2000 Sinphar TPEx-listed 2002 Sinphar TWSE-listed 2014 SynCoreBio TPEx-listed 1977 2002 2012 Established Sinphar Invested in Sinphar TianLi & Merged ZuniMed Ilan, Taiwan He-Tian Tianli Biotech Generic drugs, functional food, Hangzhou (CN), Xinjiang(CN) Nantou, Taiwan cosmeti
Slide 5: Group Resource Integration and Sharing
Group Resource Integration and Sharing Sinphar & SynCore Collaborative Pharmaceutical R&D Enhancement of Pharmaceutical Anticancer Manufacturing Sinphar & Drugs (e.g., Lyophilization Process) Tian-Li Shared R&D Achievements for Mutual Benefit Sinphar & Collaborative Patent Natural Medical ZuniMed St
Slide 6: Comprehensive health promotion
Comprehensive health promotion Drugs Recovery New Product Registration in 2027: 4 Staying Healthy Youthfulness Functional Supplements Medical Cosmetology Products New Product Released in 2026: 4 New Product Released in 2026: 6 New Product Released in 2027: 5 New Product Released in 2027: 9 6
Slide 7: International Award Winning Product
International Award Winning Product 7
Slide 8: Potent Plus Soft Capsules
| | SD [Bted tetetes . SINPHAR GROUP gies #B1 Vitamir BIE SIGE Support Heart Health nie | Anti-Fatigue aa RTBU S BAMA es jy Fie U2) 3 Exclusive Anti-Fatigue Ingredients With Patents Potent Plus Soft Capsules ' Gana FBLA BNR MES 1D BE MET AE) Echinacoside QH D-Ribose M565515* « titiey ot pare™ «gh En
Slide 9: Stay healthy, stay beautiful
Stay healthy, stay beautiful Product Portfolio 2026–2027 Two Product Series and Benefits Radiant Hydration Series EXO Micro-Essence Series 3% Tranexamic Acid Whitening Essence Cream Evens Skin Tone Launch in Launch in EXO Micro-Essence Advanced 2026 Tripeptide Elastic Repairing Cream 2026 Repair Mas
Slide 10: Sinphar Health Park – Sharing Knowledge with the Public
Sinphar Health Park – Sharing Knowledge with the Public 1. In cooperation with the Yilan County Government, Sinphar has integrated Renshan Botanical Garden and Xinliao Waterfall into a route promoting healthy living. 2. Since the beginning of the year, more than 600 groups, comprising approximately
Slide 11: International Markets
International Markets Japan Vietnam • Product G, steady growth • Product G, expect to obtain license in • Product L, steady growth 2025 • Product A, steady growth • Product A, applied in 2023, expect to obtain license in 2026 Thailand • Product L, applied in 2023 • Product C, launched in 2023, stead
Slide 12: Growth
Growth New Product Launch in 2027 • Pharmaceutical products expected to obtain marketing authorization: 4 • New functional food products planned for launch: 5 • New cosmetic products planned for launch: 9 New Markets • Co-develop and manufacture with Japanese pharmaceutical companies and expand ASEA
Slide 13: SynCore Bio
SynCore Stock Code: 4192 SynCore Bio Building on the fish-derived cellular research platform, SynCore has developed proprietary fish-derived extracellular • Actively seeking partnerships for independently vesicles. In February 2026, FECV-01 obtained its International developed new drug formulations
Slide 14: Natural Resources (Raw Materials/Extracts)
Natural Resources (Raw Materials/Extracts) Memoregain® TLCT Plus Lipucan® Protygold® 天力再生® 天力速康® 杏补宜® 管花肉蓯蓉萃取物 茯苓三萜萃取物 W80 核桃肽粉 M85绿豆肽粉 (Cistanche tubulosa extract) (Poria cocos triterpenoids) W80 Walnut peptide powder M85 Mung bean peptide powder P99 豌豆肽粉 E98鹰嘴豆肽粉 P99 Pea peptide powder E98 Chickpe
Slide 15: Innovative Plant-Based Ingredients
Innovative Plant-Based Ingredients Backed by Patented Technology and Scientific Research W80 核桃肽粉 P99 豌豆肽粉 W80 Walnut peptide P99 Pea peptide powder M85绿豆肽粉 E98鹰嘴豆肽粉 M85 Mung bean peptide E98 Chickpea peptide powder 1. On the market for 1. Active health and seven years and wellness is emerging succe
Slide 16: RD research achievements
RD research achievements Walnut oil won the ITQI and Monde Selection awards in 2023 Walnut oligopeptide won 4 gold and 1 silver international patent invention awards Walnut oligopeptide Awards (2024-2025): • HI&FI Health Ingredients Gold Extract Award • Nutrition Intelligence - Application Pioneer A
Slide 17: Revenue Overview for the Same Period in Recent Years
Revenue Overview for the Unit：NTD in thousands Same Period in Recent Years 1,800,000 50.0% G 1,600,000 45.0% R O R 1,400,000 40.0% S E S T V 35.0% P E 1,200,000 H R N 30.0% O O U 1,000,000 U F E S 25.0% I A T 800,000 ( N N T 20.0% D M S D 600,000 15.0% RA ) I G N 400,000 10.0% I N 200,000 5.0% % 0 0
Slide 18: Cash Flow
Unit: NTD in Thousands Cash Flow Sinphar Group Sinphar Group Sinphar Group H1 2026 2025 H1 2025 Net Cash generated by operating activities 194,445 584,662 180,795 Net Cash used in investing activities -133,402 -224,626 -98,109 Acquisition of property, plant and equipment -72,114 -95,115 -41,969 Prep
Slide 19: Ratio
Unit: NTD in Thousands Ratio Sinphar Group Sinphar Group H1 2026 H1 2025 Debt Ratio (%) 45.6 43.4 Current Ratio (%) 204 207 Days Sales Outstanding 75 74 Days Inventory Outstanding 152 142 Pre-Tax Net Profit Margin (%) 11.52 11.78 Earnings per Share (EPS) 0.87 0.95 Dividend Year 2022 2023 2024 2025 C
Slide 20: Energy Conservation and Emissions Reduction
Energy Conservation and Emissions Reduction Energy Saving Energy Intensity Reduced by 12.38% (2025 vs 2024) (Gigajoules/revenue in millions NTD) Sinphar complies with the “Regulations on Setting Energy Conservation Objectives and Execution Plans for Energy Users” established by the Energy Administra
Slide 21: Energy Conservation and Carbon Reduction
Energy Conservation and Carbon Reduction Carbon Reduction Emission Intensity (Note) Reduced by 4.57% (2025 vs 2024) (Metric ton of Co2e/revenue in millions NTD) Note: In accordance with the principle of significance, Scope 3 emissions from employee commuting, downstream transportation, and fuel- and
Slide 22: Talent Management
Talent Management 1. Hard assets: Bronze prize winning TTQS approved vocational training center 2. Intangible assets: utilize Talent Management System (TMS) to track and learning and professional development 3. From January to August 2026, TMS recorded approximately 400 users per month on average an
Slide 23: Management Philosophy
Management Philosophy Average Monthly Salary of Group Employees (NT$ Thousands) 71 70 69 68 67 66 65 64 113年H1 114年H1 115年H1 (*Includes employee salaries, labor and health insurance contributions, Long-Term Co-hosting of the Sinphar Yilan Marathon with pension contributions, and other personnel expe
Slide 24: Corporate Social Responsibility
Corporate Social Responsibility Promoting Social Well-Being, Disease Prevention, Health Education, and Community Engagement 1. Host health forum, biotechnology camp. Create a platform to facilitate and cultivate the interaction of medical, academic, and biotechnology professionals 2. Continue to be
Slide 25: Corporate Social Responsibility
Corporate Social Responsibility Supports Education and Sports 1. Co-hosted the Sinphar Yilan Marathon with the Yilan County Government, with the event soon entering its sixth edition 2. Sponsored the Yilan County Government in hosting the National Games, National High School Athletic Games, and Nati
Slide 26: From Desert Herbal Wisdom to Scientific Validation
From Desert Herbal Wisdom to Scientific Validation 1. Classified as a top-grade medicinal herb in the Shennong Ben Cao Jing (Divine Farmer’s Classic of Materia Medica), it is now endangered. 2. Sinphar’s research into Cistanche Tubulosa began with an effort to preserve this rare and endangered deser
Slide 27: “SR RRSS
“SR RRSS SINPHAR GROUP m+ 2 & > HH Life » Health * Technology SS L—~——